Advancements in next-generation sequencing (NGS) technologies have revolutionized the study of cancer genomes. Techniques like whole-genome sequencing (WGS) and whole-exome sequencing (WES) allow researchers to comprehensively analyze the genetic material of cancer cells. These methods provide detailed insights into the mutations and alterations driving cancer, aiding in the development of targeted therapies and personalized medicine approaches.
